SC 13G

Company

Viridian Therapeutics, Inc.\DE

Filed

January 29, 2024

Accession Number

0001193125-24-018239

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →